Company / Net Income
Emergent BioSolutions Inc. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$52.6M
FY2025
5-year range
-$760.5M / $219.5M
FY2021-FY2025
Trend
+127.6%
vs FY2024
Sector context
#49 of 216
Health Care
What the data says
Emergent BioSolutions Inc.'s net income of $53M is higher than 77% of companies in the Health Care sector (FY2025). Net Income has fluctuated over the past 10 years, ranging from -$761M in FY2023 to $305M in FY2020.
Based on SEC 10-K filings.
$53M in FY2025 with a 5-year CAGR of -29.6%. Top quartile in the Health Care sector.
Improved from -$761M to $53M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -29.6%
- 10-Year CAGR
- -
Sector benchmark
Top 23% in Health CareTop 23% of 216This company $52.6M Sector average $454.3M
▼
-88.4% below sector average
Key checks
Key Insights
- 5-year CAGR of -29.6%, indicating a declining trend.
- In FY2025, net income increased 127.6% year-over-year.
- Ranks #49 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $52.6M | +127.6% |
| FY2024 | -$190.6M | +74.9% |
| FY2023 | -$760.5M | -259.4% |
| FY2022 | -$211.6M | -196.4% |
| FY2021 | $219.5M | -28.1% |
| FY2020 | $305.1M | +459.8% |
| FY2019 | $54.5M | +5.2% |
| FY2018 | $51.8M | -37.3% |
| FY2017 | $82.6M | +59.5% |
| FY2016 | $51.8M | -17.6% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026